OXA Genes and ESBL Resistance
OXA genes do not cause resistance to ESBLs—rather, OXA-type β-lactamases are a distinct class of enzymes that confer resistance to β-lactam antibiotics, separate from classic ESBLs. This is a critical conceptual distinction in understanding antimicrobial resistance mechanisms.
Understanding the Classification
The question contains a fundamental misunderstanding. OXA enzymes belong to Ambler Class D β-lactamases, while classic ESBLs (like CTX-M, TEM, and SHV variants) belong to Ambler Class A 1. These are parallel resistance mechanisms, not hierarchical ones.
Key OXA Variants in Clinical Practice
The most clinically significant OXA genes include:
OXA-48-like carbapenemases: These are Class D enzymes that confer carbapenem resistance in Enterobacterales and represent approximately 19% of carbapenem-resistant isolates globally 1
OXA-1: This narrow-spectrum β-lactamase is frequently co-detected with ESBL genes (particularly in ESBL-producing organisms) and confers resistance to piperacillin/tazobactam. OXA-1 shows a highly significant association with piperacillin/tazobactam non-susceptibility (P < 0.001) 2. It appears in 20.9% of ESBL-producing E. coli 2 and is commonly found alongside CTX-M and TEM genes 3, 4, 5
OXA-10: Detected less frequently (9-14.8% of isolates) and often co-exists with other resistance genes 6, 7
OXA-type carbapenemases in Acinetobacter: These confer carbapenem resistance in Acinetobacter species, with resistance increasing due to these enzymes 8
Clinical Implications
For Acinetobacter Species
More than 85% of Acinetobacter isolates remain susceptible to carbapenems, but resistance is increasing due to OXA-type carbapenemases 8. Sulbactam serves as an alternative therapy with direct antibacterial activity against Acinetobacter.
For Enterobacterales
When managing carbapenem-resistant Enterobacterales (CRE), rapid testing should identify specific carbapenemase families including OXA-48-like enzymes, as treatment strategies differ based on the carbapenemase type 1. OXA-48-like producers comprised 19% of meropenem-non-susceptible Enterobacterales in recent surveillance 1.
Co-resistance Patterns
OXA-1-positive isolates show significant associations with genes conferring resistance to other antibiotic classes 2. The co-carriage of OXA genes with ESBL genes (particularly CTX-M-15 and TEM-1) creates multidrug-resistant phenotypes 3, 4, 5.
Geographic Considerations
Geographic variation exists in OXA-mediated resistance patterns. OXA-1 showed highly significant associations with piperacillin/tazobactam resistance at some institutions but not others (P < 0.001 at two sites, P = 0.21 at a third) 2, emphasizing the importance of local epidemiological data for treatment decisions.
Common Pitfall
The most critical error is conflating OXA enzymes with ESBLs. OXA genes encode distinct β-lactamases that may co-exist with ESBL genes but represent separate resistance mechanisms requiring different therapeutic approaches. For OXA-48-like carbapenemase producers, novel β-lactam/β-lactamase inhibitor combinations or cefiderocol may be required, whereas classic ESBL producers typically remain carbapenem-susceptible 1.